- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05069948
Delivery of Digital Cognitive Behavioural Therapy Following Concussion (HEADON)
Delivery of Digital Cognitive Behavioural Therapy Following Concussion: HeadOn Feasibility Study
Study Overview
Detailed Description
The HeadOn study is a prospective feasibility study of patients presenting to the Emergency Department (ED). Potentially eligible patients will be contacted by a member of the research team and their consent will be sought for participation. Those not recruited at presentation to the ED will be contacted by telephone, text or email within two weeks of their concussion date to seek their participation in the study, again by a member of the research team. After consenting, the participant will be taken through the registration process for the HeadOn program. For patients who are contacted after discharge they will be taken through registration process over the telephone or if preferable will be able to return to the ED to go over the process.
At registration the participant will be invited to complete a series of patient reported measures including the Rivermead post-concussion questionnaire, Pittsburgh Sleep Quality Index, PHQ9 questionnaire and FAST alcohol questionnaire within the HeadOn program. Alongside this, a series of researcher-led anonymised data points will be collected in a separate specially designed database including demographics, date of concussion, neurological and imaging findings which will all be collected from the medical notes and imaging reports. The HeadOn program runs for five weeks following which the participant will be invited to complete the same set of outcome measures. Alongside this, all the participant will be contacted (via telephone, text or email) by a member of the research team at week 5 to complete a further five measurements: Glasgow Outcome Score Extended, mHealth App Usability questionnaire, time to return to work and a healthcare utility questionnaire. Interested participants will be invited back within two months of enrolling in the study for a more detailed qualitative interviews about HeadOn. The study will recruit for a period of 6-months or up to 100 participants.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Edinburgh, United Kingdom, EH16 4SA
- Edinburgh Royal Infirmary
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 16 years and older (no upper age limit)
- Presenting to the ED with a concussion
- Concussion defined as a traumatically induced alteration of mental status (either defined as loss of consciousness and/or amnesia)
- Patient is Glasgow Coma Scale score of 13-15 on initial presentation to the ED
- Patient needs to be able to start using HeadOn within 14 days of their head injury
Exclusion Criteria:
- Patients aged under 16 years old
- Patients requiring surgical management of their cranial injury
- Significant other associated injuries requiring hospitalisation (spinal injury, fractures, abdominal, cardiothoracic or vascular injuries)
- Does not have capacity to give consent
- Non-English speakers
- Patient in police custody or in prison
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HeadOn intervention
Participants are given access to HeadOn - a web application that delivers a CBT programme to patients following concussion.
|
HeadOn is a web application which takes the participant through a 5-stage CBT programme including: (i) understanding post-concussion symptoms; (ii) sleep after a concussion; (iii) lifestyle habits and exercise; (iv) managing negative thought patterns and (v) returning to baseline.
The programme is delivered through a combination of weekly tasks (such as completing symptom diary, setting exercise goals and setting up a sleep time routine), audio/video media and reading material.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant Compliance With HeadOn Program
Time Frame: 5 weeks
|
Degree of engagement of study participants with the HeadOn program.
This was defined as whether the participant entered data into the HeadOn functionality (including symptom diary, sleep time setting, alcohol tracker, exercise day setting, thought diary and goal setter)
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mHealth App Usability Questionnaire
Time Frame: 5 weeks
|
The mobile Health App Usability Questionnaire (MAUQ) is a validated questionnaire that examine participants' attitudes to an mHealth intervention.
MAUQ quantifies respondents' perceptions of the usability of a mobile health app using a range from 1 to 7. A score of 7 indicates a high degree of usability.
|
5 weeks
|
|
Rivermead Post-concussion Questionnaire
Time Frame: 5 weeks
|
The Rivermead Post-Concussion Symptom Questionnaire (RPQ) is a self-report scale to measure the severity of post-concussive symptoms following a Traumatic Brain Injury.
It examines 16 post-concussion symptoms which are rates from 0 (no symptom) to 4 (severe symptom).
This gives a range from 0 (o post-concussion symptoms) to 64 (severe post-concessional symptoms).
|
5 weeks
|
|
PHQ9 Questionnaire
Time Frame: 5 weeks
|
The Patient Health Questionnaire (PHQ)-9 is the depression module, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
Range include 0 (no depression) to 27 (severe depression).
|
5 weeks
|
|
Glasgow Outcome Score Extended
Time Frame: 5 weeks
|
The Glasgow Outcome Scale (GOS) is a global scale for functional outcome that rates patient status.
There are 8 categories that are denoted numerically as follows: Dead (1), Vegetative State (2), Lower Severe Disability (3), Upper Severe Disability (4), Lower Moderate Disability (5), Upper Moderate Disability (6), Lower Good Recovery (7), and Upper Good Recovery (8).
|
5 weeks
|
|
Return to Work Rate
Time Frame: 5 weeks
|
Patient self reported outcome measure.
Participants were contacted by telephone at the completion of HeadOn (5 weeks from registration) and asked the following question 'Have you returned to work?'.
The outcome was dichotomous and was either coded as 'yes' or 'no' based on participant response.
The measure was then reported as a return to work rate which was the percentage of participants who reported they had returned to work at the completion of HeadOn.
|
5 weeks
|
|
Healthcare Resource Utilisation
Time Frame: 5 weeks
|
Patient Self reported outcome measure.
At completion of the HeadOn program (5 weeks from registration), the participants were contacted by telephone and were asked 'Have you sought healthcare professional support due to your post-concussion symptoms since you started using HeadOn?'.
The outcome was a dichotomous outcome and was either coded as 'yes' or 'no'.
The definition of healthcare professional included: returning to the emergency department, seeing family doctor, a neuropsychologist, physiotherapist or sports medicine doctor).
The outcome measure was reported as the percentage of respondents who sought healthcare professional input while using HeadOn.
|
5 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Aimun Jamjoom, FRCS, University of Edinburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021/0151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Concussion, Mild
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; University of Ottawa; British Columbia Children... and other collaboratorsNot yet recruitingMild Traumatic Brain Injury, Concussion | Concussions | Concussion MildCanada
-
Sync-Think, Inc.CompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion; Eye | Concussion, CerebralUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
Medstar Health Research InstituteNot yet recruitingConcussion, Mild | Concussion, Severe | Concussion, Intermediate
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
Akiva CohenActive, not recruiting
-
University of British ColumbiaUnknownConcussion | Sport-related Concussion | Mild Traumatic Brain Injury (MTBI)Canada